J. Safra Sarasin Holding’s Idexx Laboratories IDXX Stock Holding History

J. Safra Sarasin Holding’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.51M	Buy	4,666 +686	+17%	+$385K	0.04%	224
2026 Q1	$2.23M	Sell	3,980 -64	-2%	-$41K	0.04%	188
2025 Q4	$2.74M	Sell	4,044 -197	-5%	-$134K	0.04%	174
2025 Q3	$2.71M	Buy	4,241 +631	+17%	+$383K	0.04%	188
2025 Q2	$1.94M	Buy	3,610 +1,538	+74%	+$735K	0.03%	224
2025 Q1	$870K	Sell	2,072 -421	-17%	-$183K	0.02%	361
2024 Q4	$1.03M	Buy	2,493 +426	+21%	+$187K	0.02%	323
2024 Q3	$1.04M	Sell	2,067 -65	-3%	-$31.6K	0.02%	330
2024 Q2	$1.04M	Buy	+2,132	New	+$1.07M	0.02%	337

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

J. Safra Sarasin Holding's IDXX Position: Q2 2026 in Review

J. Safra Sarasin Holding increased its Idexx Laboratories (IDXX) stake by 17% in Q2 2026, buying an estimated $385K and bringing the position to 4,666 shares worth $2.51M. The position accounts for 0.04% of the portfolio, ranked #224.

J. Safra Sarasin Holding first reported a position in IDXX in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.74M in Q4 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

J. Safra Sarasin Holding held 4,666 shares of Idexx Laboratories worth $2.51M as of Q2 2026.
J. Safra Sarasin Holding bought 686 Idexx Laboratories shares in Q2 2026, an estimated $385K.
Idexx Laboratories made up 0.04% of J. Safra Sarasin Holding's portfolio in Q2 2026, its #224 holding.
J. Safra Sarasin Holding first reported a position in Idexx Laboratories in Q2 2024 and has held it in 9 quarters since.
J. Safra Sarasin Holding's Idexx Laboratories position peaked at $2.74M in Q4 2025.
1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on J. Safra Sarasin Holding's 13F filing for Q2 2026, filed 31 Jul 2026.